Dr Emma Allott's research integrates epidemiologic methods and design with molecular tumour profiling to identify mechanisms linking dietary and lifestyle factors with cancer risk and progression. She directs omics and immunohistochemistry analyses of archival tissue specimens to generate molecular epidemiology resources, and leads a research program focused on the role of statin use, high serum cholesterol and dysregulated tumour lipid metabolism in prostate cancer progression. In addition, she collaborates with a number of existing studies, both in the US and Ireland, integrating immunohistochemistry and genome wide expression profiling with clinical and epidemiologic data in large cohorts of breast and prostate cancer.